RESUMO
Traditionally, antibiotic growth promoters (AGP) have been used in foodstock animals to reduce enteric inflammation and maintain intestinal homeostasis, thus improving growth and performance. Due to increasing restrictions regarding the use of AGP however, precise and high throughput enteric inflammation models and markers to search for effective alternatives are urgently needed. In this paper, oral administration of fluorescein isothiocyanate dextran (FITC-d, 3-5 kDa) and its passage into blood was used as a marker for tight junction permeability. In experiement 1, broilers were assigned to a control group, a group which received 24 h feed restriction (FR), or a group which received dextran sodium sulfate (DSS) (0.75% in water for 5 d), and each group then underwent an oral gavage of FITC-d 2.5 h before sample collection on d10. FITC-d in serum and intestinal samples (duodenum and ceca) were found to be higher (P<0.05) after FR than in the DSS and control groups. In experiment 2, FR was evaluated for its effect on mucosal leakage and an oral dose of FITC-d of 0.5, 1.1, or 2.2 mg/chick was used to measure the gastrointestinal tract (GIT) permeability at 6 d of age. The amount of FITC-d remaining in the duodenal tissue of the control birds increased with dose, only the 1.1 mg FITC-d/chick dose resulted in differences (P<0.05) between the control and FR groups. No differences were noted between the control and FR groups, regardless of FITC-d dosage in cecal recovery of FITC-d. Additionally, FR increased FITC-d serum levels when compared to the control group and in a dose-dependent manner. Experiment 3 compared serum levels after administration of 0.55 and 1.1 mg/chick doses of FITC-d in birds treated with FR, rye-based diet (RBD), and DSS. Intestinal sections were collected for FITC-d recovery in the 1.1 mg dosage group. All inflammation treatments significantly increased serum FITC-d levels at both doses. Only FR resulted in increased (P<0.05) FITC-d recovery from duodenum, ileum, and ceca. In conclusion, FR, DSS, and RBD affected GIT tight junction integrity, suggesting their value for enteric inflammation models, and FITC-d may be a good indicator of permeability.
Assuntos
Restrição Calórica/veterinária , Galinhas/fisiologia , Sulfato de Dextrana/farmacologia , Dextranos/sangue , Dieta/veterinária , Fluoresceína-5-Isotiocianato/análogos & derivados , Inflamação/fisiopatologia , Administração Oral , Ração Animal/análise , Animais , Restrição Calórica/efeitos adversos , Ceco/efeitos dos fármacos , Ceco/fisiologia , Dieta/efeitos adversos , Relação Dose-Resposta a Droga , Duodeno/efeitos dos fármacos , Duodeno/fisiologia , Íleo/efeitos dos fármacos , Íleo/fisiologia , Inflamação/induzido quimicamente , Mucosa Intestinal/efeitos dos fármacos , Permeabilidade , Polissacarídeos/efeitos adversos , Distribuição Aleatória , Estresse Fisiológico , Junções Íntimas/efeitos dos fármacos , Junções Íntimas/fisiologiaRESUMO
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a major cause of intestinal disease and hemolytic uremic syndrome, a serious systemic complication that particularly affects children. Cattle are primary reservoirs for EHEC O157:H7 and the main source of infection for humans. Vaccination of cattle with different combinations of bacterial virulence factors has shown efficacy in decreasing EHEC O157:H7 shedding. It is, therefore, important to demonstrate whether vaccination of pregnant cows with EHEC O157:H7 induces high titers of transferable antibodies to avoid early colonization of calves by the bacteria. In this study we evaluated the ability of EspA, EspB, the C-terminal fragment of 280 amino acids of γ-intimin (γ-intimin C280) and inactivated Shiga toxin (Stx) 2 proteins to induce specific antibodies in colostrum and their passive transference to colostrum-fed calves. Friesian pregnant cows immunized by the intramuscular route mounted significantly high serum and colostrum IgG responses against EspB and γ-intimin C280 that were efficiently transferred to their calves. Antibodies to EspB and γ-intimin C280 were detected in milk samples of vaccinated cows at d 40 postparturition. Significant Stx2-neutralizing titers were also observed in colostrum from Stx2-vaccinated cows and sera from colostrum-fed calves. The results presented showed that bovine colostrum with increased levels of antibodies against EHEC O157:H7 may be obtained by systemic immunization of pregnant cows, and that these specific antibodies are efficiently transferred to newborn calves by feeding colostrum. Hyperimmune colostrum and milk may be an alternative to protect calves from early colonization by EHEC O157:H7 and a possible key source of antibodies to block colonization and toxic activity of this bacterium.
Assuntos
Adesinas Bacterianas/farmacologia , Anticorpos Antibacterianos/imunologia , Proteínas da Membrana Bacteriana Externa/farmacologia , Bovinos/imunologia , Colostro/imunologia , Escherichia coli O157/imunologia , Proteínas de Escherichia coli/farmacologia , Imunidade Materno-Adquirida/imunologia , Toxina Shiga II/farmacologia , Vacinação/veterinária , Adesinas Bacterianas/imunologia , Animais , Animais Recém-Nascidos/imunologia , Proteínas da Membrana Bacteriana Externa/imunologia , Proteínas de Escherichia coli/imunologia , Feminino , Gravidez , Toxina Shiga II/imunologiaRESUMO
Foot and Mouth Disease Virus (FMDV) causes economy losses and is controlled by vaccination in many countries. Vaccine formulations based on empty capsids or Virus-Like Particles (VLPs) have the advantage of avoiding the biological hazard of using infectious FMDV, albeit are poorly immunogenic. Recently, we have described that ISPA a new Immune Stimulating Complex adjuvant, is useful to improve the response against FMD of vaccines that use inactivated virus. Now, the adjuvant effects of ISPA and ISA 206 (water/oil/water) on a VLPs-based FMD vaccine were evaluated. VLPs (strain A/Argentina/2001) were obtained in mammalian cell cultures and their elicitation of an immune response against FMDV with and without ISPA or ISA 206 was evaluated in mice as a first approach. Notably, VLPs-ISPA and VLPs-ISA 206 vaccines induced protection against viral challenge in 100 % of mice, while protection induced by VLPs alone was of 40 %. Total and neutralizing FMDV antibodies were higher in the VLPs-ISPA and VLPs-ISA 206 groups compared to the VLPs group. VLPs-ISPA induced significantly higher (p < 0.001) IgG1, IgG2a, IgG2b and IgG3 titers than the VLPs vaccine. Moreover, in comparison with non-adjuvanted VLPs, VLPs-ISPA and VLPs-ISA 206 elicited an increased virus-specific T response, including higher IFNγ+/CD8 + lymphocyte production in mice. When these vaccines were tested in calves, antibody titers reached an Expected Percentage of Protection (EPP) above 90 % in the case of the VLPs-ISPA and VLPs-ISA 206 vaccines, while, in the VLPs group, EPP reached 25 %. IFNγ levels secreted by mononuclear cells of VLP-ISPA-vaccinated cattle were significantly higher than in the VLPs group. Overall, the results demonstrate that VLPs-ISPA or VLPs-ISA 206 are promising formulations for the development of a novel FMD vaccine.
Assuntos
Vírus da Febre Aftosa , Febre Aftosa , Vacinas de Partículas Semelhantes a Vírus , Vacinas Virais , Animais , Anticorpos Neutralizantes , Anticorpos Antivirais , Capsídeo , Bovinos , Mamíferos , CamundongosRESUMO
The apicomplexan protozoan Cryptosporidium parvum is an important causative agent of diarrhea of neonatal bovines. Vaccination has been proposed as an advantageous strategy against cryptosporidiosis of calves since besides protection against disease it has also the potential to prevent dissemination of infective oocysts into the environment. Antigens anchored to the parasite surface via glycosylphosphatidylinositol (GPI) are implicated in host cell attachment and invasion and represent promising vaccine candidates. A reverse vaccinology approach was employed to (i) identify the GPI-anchored proteome of C. parvum using available web-based bioinformatic tools and (ii) characterize previously unrecognized novel vaccine antigens. Altogether, 14 putative GPI-anchored proteins could be determined of which CpH1 and CpSUB2 as well as GP60 were further characterized. Sequencing and comparison of GP60, CpH1, and CpSUB1 alleles amplified from different geographic isolates showed a high degree of conservation. All three antigens were recombinant expressed and immunoblotted using sera of 12 Cryptosporidium-infected calves sampled at age periods 1-11 and 12-28 days after birth. Specific antibody reactions against the studied antigens were detected in all analyzed calves, demonstrating their immunreactivity and expression, and recognition in vivo at an early stage of host infection. Besides the acknowledged GP60 vaccinogen, the presented reverse vaccinology approach reveals the additional vaccine candidates CpH1 and CpSUB1 for inclusion into a subunit vaccine formulation.
Assuntos
Doenças dos Bovinos/prevenção & controle , Criptosporidiose/prevenção & controle , Vacinas Protozoárias/imunologia , Animais , Animais Recém-Nascidos , Anticorpos Anti-Helmínticos/sangue , Antígenos de Protozoários/genética , Antígenos de Protozoários/imunologia , Bovinos , Doenças dos Bovinos/imunologia , Doenças dos Bovinos/parasitologia , Criptosporidiose/imunologia , Criptosporidiose/parasitologia , Cryptosporidium/imunologia , Proteínas Recombinantes/imunologia , Vacinas Sintéticas/imunologia , VacinologiaRESUMO
We report the first isolation of Histoplasma capsulatum var. capsulatum from a male bat Eumops bonariensis captured in Buenos Aires city in 2003. The pathogen was recovered from spleen and liver specimens, and was identified by its phenotypic characteristics. PCR with primers 1283, (GTG)5, (GACA)4 and M13 was used to compare both bat isolates with 17 human isolates, 12 from patients residing in Buenos Aires city, and 5 from other countries of the Americas. The profiles obtained with the four primers showed that both bat isolates were identical to each other and closer to Buenos Aires patients than to the other isolates (similarity percentage: 91-100% and 55-97%, respectively). The high genetic relationship between bat isolates and those from patients living in Buenos Aires suggests a common source of infection. This is the first record of E. bonariensis infected with H. capsulatum in the world, and the first isolation of the fungus in the Argentinean Chiroptera population. In the same way as these wild mammals act as reservoir and spread the fungus in the natural environment, infection in urban bats could well be associated with the increase in histoplasmosis clinical cases among immunosuppressed hosts in Buenos Aires city.
Assuntos
Quirópteros/microbiologia , Histoplasma/isolamento & purificação , América , Animais , Argentina/epidemiologia , Quirópteros/classificação , DNA Fúngico/genética , Reservatórios de Doenças , Histoplasma/genética , Histoplasmose/epidemiologia , Histoplasmose/microbiologia , Histoplasmose/transmissão , Humanos , Hospedeiro Imunocomprometido , Fígado/microbiologia , Masculino , Infecções Oportunistas/epidemiologia , Infecções Oportunistas/microbiologia , Infecções Oportunistas/transmissão , Especificidade da Espécie , Baço/microbiologia , Saúde da População UrbanaRESUMO
RESUMEN La Esclerosis Sistémica (ES) es una enfermedad autoinmune crónica con la tasa más alta de mortalidad y morbilidad entre las enfermedades reumáticas, se caracteriza por daño vascular y fibrosis tanto cutáneo como de órganos internos. Se presenta una serie de cuatro casos clínicos de pacientes femeninos ecuatorianos afectos de dicha patología, en concomitancia con otros padecimientos autoinmunes diagnosticados y en seguimiento en el Hospital General Docente de Calderón de la ciudad de Quito.
ABSTRACT Systemic sclerosis (ES) is a chronic autoimmune disease with a higher rate of mortality and morbidity among rheumatic diseases, it is vascular damage and both skin fibrosis and internal internals. We present a series of four clinical cases of Ecuadorianfemale patients affected by the said pathology, in concomitance with other autoimmune diseases, diagnosis and follow-up in the General Teaching Hospital of Calderón in the city of Quito Ecuador.
RESUMO
Bovine coronavirus (BCoV) is an important viral pathogen associated with neonatal calf diarrhea. Our aim was to investigate the incidence of BCoV in diarrhea outbreaks in beef and dairy herds from Argentina during 1994-2010. A total of 5.365 fecal samples from diarrheic calves were screened for BCoV diagnosis by ELISA. The virus was detected in 1.71% (92/5365) of the samples corresponding to 5.95% (63/1058) of the diarrhea cases in 239 beef and 324 dairy farms. The detection rate of BCoV was significantly higher in dairy than in beef herds: 12.13% (29/239) vs. 4.32% (14/324) respectively. Phylogenetic analysis of the hypervariable S1 region of seven representative samples (from different husbandry systems, farm locations and years of sampling) indicated that BCoV strains circulating in Argentinean beef and dairy herds formed a cluster distinct from other geographical regions. Interestingly, Argentinean strains are distantly related (at both the nucleotide and amino acid levels) with the Mebus historic reference BCoV strain included in the vaccines currently available in Argentina. However, Mebus-induced antibodies were capable of neutralizing the BCoV Arg95, a field strain adapted to grow in vitro, and vice versa, indicating that both strains belong to the same CoV serotype reported in cattle. This work represents the first large survey describing BCoV circulation in Argentinean cattle.
Assuntos
Doenças dos Bovinos/virologia , Infecções por Coronavirus/veterinária , Coronavirus Bovino/genética , Coronavirus Bovino/imunologia , DNA Viral/análise , Filogenia , Animais , Antígenos Virais/análise , Argentina/epidemiologia , Sequência de Bases , Bovinos , Doenças dos Bovinos/epidemiologia , Infecções por Coronavirus/epidemiologia , Infecções por Coronavirus/virologia , Coronavirus Bovino/classificação , Indústria de Laticínios , Surtos de Doenças/veterinária , Fezes/virologia , Feminino , Masculino , Dados de Sequência Molecular , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sequência de DNARESUMO
Remarkable asymmetric induction is achieved in the alkylation of the lithium enolate of the beta-lactam 1. This allows the first time access to a new family of peptidomimetics 2 with predictable conformational constraints.
RESUMO
Escherichia coli O157:H7 is responsible for severe intestinal disease and hemolytic uremic syndrome (HUS), a serious systemic complication which particularly affects children. Cattle are the primary reservoir for E. coli O157:H7 and the main source of infection for humans. In this study, we evaluated the ability of transferred maternal colostral antibodies against γ-Intimin C280 and EspB, to protect young weaned calves from E. coli O157:H7 infection. Hyperimmune colostra were obtained by immunization of pregnant cows with a mix of the mentioned antigens. All vaccinated cows mounted a significant IgG response against γ-Intimin C280, and EspB in sera and colostra. Colostrum-fed calves also exhibited high serum IgG titers against γ-Intimin C280 and EspB along with a rise in mucosal γ-Intimin C280-specific IgG antibodies at recto-anal junction and ileum. Additionally, 70 day-old calves received a challenge with E. coli O157:H7 but no reduction in total bacterial shedding or frequency of E. coli O157:H7 excretion from these calves was observed. Most tissue samples showed granulocyte focal infiltrations of the lamina propria and enterocyte erosion. In conclusion, up to the 70th day, the passively acquired γ-Intimin-C280 and EspB-IgG antibodies present in sera and recto-anal mucosa reached a titer insufficient to reduce EHEC O157 shedding and damages of experimentally inoculated young calves.
Assuntos
Adesinas Bacterianas/imunologia , Anticorpos Antibacterianos/imunologia , Proteínas da Membrana Bacteriana Externa/imunologia , Doenças dos Bovinos/prevenção & controle , Colostro/imunologia , Infecções por Escherichia coli/veterinária , Proteínas de Escherichia coli/imunologia , Animais , Anticorpos Antibacterianos/sangue , Derrame de Bactérias , Bovinos , Doenças dos Bovinos/imunologia , Infecções por Escherichia coli/imunologia , Infecções por Escherichia coli/prevenção & controle , Escherichia coli O157 , Vacinas contra Escherichia coli/administração & dosagem , Fezes/microbiologia , Feminino , Imunidade Materno-Adquirida , Imunidade nas Mucosas , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , GravidezRESUMO
Bovine Group A Rotavirus (RVA) is one of the main causes of neonatal calf diarrhea worldwide. The present study reports the genotyping of bovine RVA strains circulating in Argentinean cattle from 2004 to 2010. Additionally, a new set of typing primers was designed and tested to differentiate between G8 and G6 (lineage III and IV) RVA strains. Bovine RVA was detected in 30% (435/1462) of the tested samples, corresponding to 49% (207/423) of the studied outbreaks with a similar detection rates in beef (53%; 67/127) and dairy herds (52%; 65/126). The RVA strains circulating in Argentinean cattle belonged to the common bovine genotypes G6 (lineages III and IV), G8, G10, P[5] and P[11]. A different RVA G/P-genotype distribution was found between the exploitation types, with the combination G6(IV)P[5] being by fare the most prevalent RVA strain in beef herds (58%), whereas a more even distribution of G6(III)P[11] (15%), G10P[11] (17%), G6(IV)P[5] (14%), and G6(IV)P[11] (6%) RVA strains was detected in dairy herds. G8 RVA strains were found in two dairy farms in calves co-infected with G8+G6(III)P[11]. A high percentage of co-infections and co-circulation of RVA strains with different genotypes during the same outbreak were registered in both exploitation types (20% of the outbreaks from beef herds and 23% from dairy herds), indicating a potential environment for reassortment. This finding is significant because G10P[11] and G6(III)P[11] strains may possess zoonotic potential. Continuous surveillance of the RVA strains circulating in livestock provides valuable information for a better understanding of rotavirus ecology and epidemiology.
Assuntos
Doenças dos Bovinos/virologia , Infecções por Rotavirus/veterinária , Infecções por Rotavirus/virologia , Rotavirus/genética , Animais , Argentina/epidemiologia , Sequência de Bases , Bovinos , Doenças dos Bovinos/epidemiologia , Coinfecção/veterinária , Primers do DNA/genética , Fezes/virologia , Genótipo , Dados de Sequência Molecular , Filogenia , Prevalência , Rotavirus/classificação , Infecções por Rotavirus/epidemiologia , Alinhamento de SequênciaRESUMO
El término alergia alimentaria se refiere a los eventos adversos a alimentos originados por mecanismo inmunológico. La alergia alimentaria puede aparecer en cualquier etapa de la vida. Es un padecimiento que, en general, se manifiesta en el lactante por llanto excesivo, cólicos, vómitos, diarreas, acompañadas de sangre y eccema en la piel. El objetivo de la investigación es demostrar la sensibilización del lactante a los alérgenos alimentarios que recibió en el útero de la madre y a través de la lactancia materna exclusiva. La metodología fue reporte de un caso al que se le suspendió la lactancia materna exclusiva y se introdujo leche en polvo hipoalergénica Puramino. La IgE total fue de 1.136 kU/l y los valores de IgE alérgeno específico para leche, el huevo y el maní mayores de 100 kU/l y para el trigo 24,4 kU/l. Se concluye así que la leche de vaca, el huevo, el maní y el trigo pueden sensibilizar al niño durante el embarazo y a través del seno materno. El uso de una dieta hipoalergénica durante el período de lactante puede revertir el proceso.(AU)
The term food allergy refers to adverse events caused by immunologic mechanism. Food allergy may appear at any stage of life, it is a condition that generally manifests itself in the baby's excessive crying, colic, vomiting, diarrhea accompanied by blood and skin eczema. The objective of the research is to demonstrate awareness infant to food allergens received in the mother's womb and through the exclusive breastfeeding. The methodology was a case report that was suspended exclusive breastfeeding and milk powder was introduced into hypoallergenic Puramino. The total IgE was 1.136 kU/L and allergen specific IgE values for milk, egg and peanut higher than 100 kU/L and wheat: 24. 4 kU/L. It is concluded that cow's milk, egg, peanuts and wheat can sensitize the child during pregnancy and through the womb. The use of a hypoallergenic diet during the infant can reverse the process.(AU)
Assuntos
Humanos , Masculino , Feminino , Gravidez , Lactente , Hipersensibilidade Alimentar , Lactente , Arachis , Triticum , Aleitamento Materno , Teste de Radioalergoadsorção , Micronutrientes , Substitutos do Leite Humano , Sistema ImunitárioRESUMO
El tratamiento de la alergia alimentaria consiste en educar al paciente para evitar la ingestión y, cuando ello no es posible, emplear, entre otros procedimientos, la inmunoterapia con el alimento causal. El objetivo de esta revisión es presentar evidencias sobre eficacia y seguridad de la inmunoterapia en alergia alimentaria y las vías recomendadas para su aplicación. Se accedió a las bases de datos con los descriptores inmunoterapia, alergia alimentaria, vías, desensibilización, eficacia y seguridad. La inmunoterapia oral (ITO) a partir de leche caliente por microondas fue eficaz con buen perfil de seguridad en niños con alergia a leche de vaca (ALV). La quimotripsina inhibe la formación de ßLg y es un nuevo candidato para la inmunoterapia oral en ALV. La ITO con leche y omalizumab ha demostrado mejoría significativa en las medidas de seguridad, pero no en los resultados de eficacia. ITO en niños con alergia al huevo desarrollan tolerancia disminuyendo el riesgo de reacciones alérgicas. También ha aumentado la tolerancia al huevo sin cocinar. En alergia al maní la ITO indujo desensibilización en niños y dio lugar a un aumento significativo en la tolerancia con buen perfil de seguridad. La coadministración del probiótico Lactobacillus rhamnosus a ITO con maní fue eficaz en la inducción de la falta de respuesta y cambios inmunes sostenidos. Se concluye que la ITO puede ser una vía eficaz y segura para la alergia a la leche, huevo y maní. Los protocolos muestran resultados diferentes en eficacia y seguridad, por lo que se requieren más ensayos clínicos.(AU)
The treatment of food allergy is to educate the patient to avoid ingestion and, when it is not possible, to use, among other procedures, the immunotherapy with the offending food. The objective of this review is to present evidence on efficacy and safety of immunotherapy in food allergy and recommended for implementation pathways. It was accessed databases with describer's immunotherapy, food allergy, pathways, desensitization, efficacy and safety. The OIT from microwave hot milk was effective with good safety profile in children with CM. Chymotrypsin inhibits the formation of ßLg and is a new candidate for oral immunotherapy CM. The OIT with milk and omalizumab has shown significant improvement in security measures, but not in the efficacy results. OIT in children with egg allergy develop tolerance decreasing the risk of allergic reactions. It has also increased tolerance uncooked egg. In peanut allergy desensitization induced OIT in children and resulted in a significant increase in tolerance with good safety profile. The co-administration of probiotic Lactobacillus rhamnosus with peanut OIT was effective in inducing immune unresponsiveness and sustained changes. It is concluded that the OIT can be an effective and safe for allergy to milk, egg and peanut route. Protocols show different results in efficacy and safety so more clinical trials are required.(AU)
Assuntos
Humanos , Masculino , Feminino , Criança , Dessensibilização Imunológica , Hipersensibilidade Alimentar/diagnóstico , Segurança , Eficácia , ImunoterapiaRESUMO
Se comunica el primer aislamiento de Histoplasma capsulatum var. capsulatum de un murciélago macho de la especie Eumops bonariensis, capturado en la ciudad de Buenos Aires en 2003. Los aislamientos fueron recuperados de bazo e hígado e identificados fenotípicamente. Se los comparó por PCR, con 17 aislamientos clínicos, 12 de pacientes residentes en la ciudad de Buenos Aires y cinco de otros países de América, usando los iniciadores 1283, (GTG)5, (GACA)4 y M13. Con los cuatro iniciadores, los perfiles de los aislamientos de murciélago resultaron idénticos entre sí y más relacionados a los de pacientes de Buenos Aires que a los de otros países (porcentaje de similitud: 91-100% y 55-87%, respectivamente). La alta relación genética entre los aislamientos obtenidos del murciélago y de los humanos residentes en Buenos Aires sugiere una fuente común de infección. Este es el primer registro de E. bonariensis infectado con H. capsulatum en el mundo, y el primer aislamiento del hongo en la población de quirópteros de la Argentina. Así como estos mamíferos actúan como reservorio y dispersan el hongo en la naturaleza, la infección en murciélagos urbanos podría asociarse al elevado número de casos de histoplasmosis entre pacientes inmunodeprimidos en la ciudad de Buenos Aires.
We report the first isolation of Histoplasma capsulatum var. capsulatum from a male bat Eumops bonariensis captured in Buenos Aires city in 2003. The pathogen was recovered from spleen and liver specimens, and was identified by its phenotypic characteristics. PCR with primers 1283, (GTG)5, (GACA)4 and M13 was used to compare both bat isolates with 17 human isolates, 12 from patients residing in Buenos Aires city, and 5 from other countries of the Americas. The profiles obtained with the four primers showed that both bat isolates were identical to each other and closer to Buenos Aires patients than to the other isolates (similarity percentage: 91-100% and 55-97%, respectively). The high genetic relationship between bat isolates and those from patients living in Buenos Aires suggests a common source of infection. This is the first record of E. bonariensis infected with H. capsulatum in the world, and the first isolation of the fungus in the Argentinean Chiroptera population. In the same way as these wild mammals act as reservoir and spread the fungus in the natural environment, infection in urban bats could well be associated with the increase in histoplasmosis clinical cases among immunosuppressed hosts in Buenos Aires city.